Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyHealthfirst EMG/NCS Coverage & Policy Update | Ope…
    Ask Trek AI about this page
    CurrenthealthfirstofnewyorkPolicy PO-RE-140v2

    Electromyography and Nerve Conduction Studies (EMG/NCS) Reimbursement Policy

    Customize your policy alerts

    Sign up for healthfirstofnewyork Policy PO-RE-140v2 alerts

    Get alerted when Policy PO-RE-140v2 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Reimbursement and billing guidelines for EMG and NCS performed for Healthfirst members across identified lines of business; applies to providers performing these diagnostic services and outlines documentation, supervision, limitations, and coding requirements.

    Policy Summary
    Payerhealthfirstofnewyork
    PolicyElectromyography and Nerve Conduction Studies (EMG/NCS) Reimbursement Policy
    Policy CodePolicy PO-RE-140v2
    Change TypeRevision (provider qualifications and PT scope clarified)
    Effective DateSep 1, 2025
    Last ReviewJul 20, 2026
    Next Review Date
    Key ActionSubmit EMG/NCS requests to Healthfirst's Utilization Management with complete documentation showing physician oversight and real-time response parameters to support reimbursement.
    SourceLink
    POLICY UPDATE CHANGES

    Qualified provider requirements were revised to require that electrodiagnostic testing be ordered and overseen by a qualified physician, with documentation supporting the physician's review of the findings and resulting diagnosis.

    Physician qualification language was revised by removing references to specific specialty training, credentialing standards, and examples of qualified physician specialties.

    Added requirements for EMG testing performed by physical therapists, including appropriate certification and qualifications, performance pursuant to a referring physician's order, and compliance with applicable state law.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ~20procedure and code references provided
    MultipleLines of business covered
    SeveralNot-covered scenarios
    MP-093 / LCD L35098Cross-references

    Medical Necessity, Provider Qualifications, and Limitations

    Medical necessity and documentation criteria

    Covered when ALL of the following are met:

    ALL of the following

    • The test is medically necessary for diagnosis, evaluation, or management of peripheral nerve or neuromuscular disorders (e.g., peripheral neuropathy, radiculopathy, nerve entrapments, neuromuscular junction disorders) or provides guidance for procedures.
    • The test is performed by qualified healthcare professionals with appropriate training and clinical expertise.
    • Documentation supports clinical indication, procedures performed, response parameters obtained, provider qualifications, interpretation of results, and type of equipment used.
    • Requests for testing are subject to review by Healthfirst Utilization Management using the criteria in MP-093; final reimbursement is subject to member benefits and provider contract.
    Repeat testing is justified only when there are clinical changes, inconclusive initial results, or for disease monitoring, and the repeat study is documented accordingly.

    Provider qualifications and supervision

    Provider performance and supervision requirements depend on line of business and applicable state law; ALL applicable items below must be satisfied.

    ALL of the following

    • Medicare lines of business (MA HMO, MA PPO, CompleteCare, IB-Dual):

      • Healthfirst follows applicable CMS guidelines including LCD L35098 for EMG/NCS; supervision and performance must align with those CMS rules.
    • Other Lines of Business (CHP, MMC, EP, HARP, QHP):

      • Testing should be ordered and overseen by a qualified physician with expertise in neurological conditions (e.g., neurologist, physiatrist) or a physician meeting equivalent training/credentialing standards.
    • Physical Therapists (PT) may perform specified procedures only if they hold ABPTS certification and any additional procedural certification required, and only as permitted by state law and the supervision indicators assigned to the CPT code.

    Limitations & exclusions

    The following scenarios are NOT covered or are limited:

    Non-covered or excluded scenarios

    • Routine screening for diabetic or ESRD-related neuropathy without specific clinical indications is not covered.
    • NCS that do not provide real-time response parameters (amplitude, latency, conduction velocity) will not be reimbursed.
    • Data transmitted electronically or over the internet without real-time response data, or tests performed with portable or automated devices that assess only limited parameters, are not considered medically necessary.
    • NCS performed with fixed templates or computer-generated reports as routine adjuncts are not acceptable.
    • Repetitive stimulation testing for diabetic neuropathy or routine carpal/tarsal tunnel syndrome screening is not covered unless there is clinical suspicion of a neuromuscular disorder.

    EMG/NCS Codes and Technical Requirements

    EMG CPT Codes (covered)CPTCovered
    95860Needle electromyography; 1 extremity with or without related paraspinal areas.
    95861Needle electromyography; 2 extremities with or without related paraspinal areas.
    95863Needle electromyography; 3 extremities with or without related paraspinal areas.
    95864Needle electromyography; 4 extremities with or without related paraspinal areas.
    95867Needle electromyography; cranial nerve supplied muscle(s), unilateral.
    95868Needle electromyography; cranial nerve supplied muscle(s), bilateral.
    95869Needle electromyography; thoracic paraspinal muscles (excluding T1 or T12).
    95870Needle electromyography; limited study of muscles in 1 extremity or non-limb (axial) muscles (unilateral or bilateral), other than thoracic paraspinal, cranial nerve.
    95885Needle Electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (list separately in addition to code for primary).
    95886Needle Electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscle studied, innervated by three or more nerves or four or more spinal LE.
    1–10 of 11
    1/2
    Nerve Conduction Study CPT Codes (covered)CPTCovered
    95907Nerve conduction studies; 1-2 studies.
    95908Nerve conduction studies; 3-4 studies.
    95909Nerve conduction studies; 5-6 studies.
    95910Nerve conduction studies; 7-8 studies.
    95911Nerve conduction studies; 9-10 studies.
    95912Nerve conduction studies; 11-12 studies.
    95913Nerve conduction studies (listed in source as part of series 95907-95913).
    Other EMG/NCS CPT Codes (covered)CPTCovered
    95937Neuromuscular Junction Testing (TC/PC supervision noted)
    Real-time response data requirement — NCS parameters (amplitude, latency, conduction velocity) requirement for reimbursement
    Required real-time NCS response parametersAmplitude, latency, and conduction velocity must be recorded and included in the study; NCS lacking these detailed real-time response data will not be reimbursed.
    Documentation must record response parametersClaims must include the response parameters obtained as part of the required documentation to support reimbursement.
    Excluded data transmission methodsData transmitted electronically or over the internet without accompanying real-time response data are not acceptable for reimbursement.
    Device limitationsPortable or automated nerve conduction devices that test only limited parameters, or studies using fixed templates or computer-generated reports as routine adjuncts, are not considered medically necessary and will not be reimbursed.
    Relation to repeat testing and justificationRepeat NCS must be justified by clinical change, disease monitoring, or inconclusive initial studies and still must include real-time response parameters to be reimbursed.

    Prior Authorization and Claim Adjudication

    Prior Authorization

    Prior authorization and claim adjudication: UM review per MP-093

    Requests for EMG/NCS testing will be reviewed by Healthfirst's Utilization Management (UM) team using the criteria in MP-093; final reimbursement is determined by benefit coverage and the provider's contract, and claims not adhering to this policy will be denied or rejected.

    • Reimbursement determined by provider contract and benefit coverage per MP-093.
    • Providers are responsible for accurate coding; non-adherent claims will be denied or rejected.
    • Final reimbursement depends on medical necessity, state/federal mandates, and timely filing rules in the provider contract.

    Key Terms

    Nerve Conduction studies (NCS) — definition
    DefinitionNerve conduction studies (NCS) measure action potentials resulting from peripheral nerve stimulation, recordable over the nerve or from an innervated muscle.
    TypesTwo general types: sensory and motor nerve conduction studies.
    Recording methodsResponses may be recorded using surface or needle electrodes for stimulation or recording.
    Electromyography (EMG) — definition
    DefinitionElectromyography (EMG) is the study and recording of intrinsic electrical properties of skeletal muscles, relying on auditory and visual feedback to the electromyographer.
    TechniqueEMG testing is invasive and typically performed with needle electrode insertion and adjustment at multiple sites, including anatomically critical sites.

    Material Changes and Policy Updates

    2026-07-20policy_revisionLatest

    Revised qualified provider requirements to require electrodiagnostic testing be ordered and overseen by a qualified physician with documentation of the physician's review and diagnosis; physician qualification language was broadened by removing references to specific specialty training and credentialing examples.

    2025-09-01effective_date

    Policy effective date established for the revised EMG/NCS reimbursement and documentation requirements.

    Policy Summary
    Payerhealthfirstofnewyork
    PolicyElectromyography and Nerve Conduction Studies (EMG/NCS) Reimbursement Policy
    Policy CodePolicy PO-RE-140v2
    Change TypeRevision (provider qualifications and PT scope clarified)
    Effective DateSep 1, 2025
    Last ReviewJul 20, 2026
    Next Review Date
    Key ActionSubmit EMG/NCS requests to Healthfirst's Utilization Management with complete documentation showing physician oversight and real-time response parameters to support reimbursement.
    SourceLink
    On This Page
    Medical Necessity, Provider Qualifications, and LimitationsEMG/NCS Codes and Technical RequirementsPrior Authorization and Claim AdjudicationKey TermsMaterial Changes and Policy Updates
    When PTs perform testing under supervision level descriptors: certified PTs may fully perform TC & PC where allowed (e.g., supervision level 7A/77 for certain NCS codes); non-certified PTs may perform the technical component (TC) only under direct physician supervision, with the PC performed by a physician as required by supervision level definitions.
  1. Certain codes carry specific supervision restrictions (e.g., CPT 95905 is not reimbursable when performed by PTs because it lacks permissible PT supervision indicators).
  2. ref': 'b0_1
    title": "Provider qualifications and supervision
    title":
  3. EMG of only intrinsic foot muscles or testing in regions with surgical scars without other supporting findings is not covered.
  4. EMG performed shortly after trauma before abnormalities are expected to be detectable is not covered.
  5. Surface or macro-EMG studies, multiple EMG studies at the same site solely to optimize botulinum toxin injections, and SEPs/SERs performed outside approved indications are not covered.
  6. ref': 'b0_2
    title": "Limitations & exclusions
    title":
    Codes to which requirement appliesApplies to NCS CPT codes 95907–95913 (studies with and without needle EMG) and to combined EMG/NCS billing; absence of real-time response parameters on these studies may result in denial.
    Coding noteNeedle EMG CPT codes include 95860–95870 and 95885–95887 as appropriate per procedure performed.